Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum

Neurochemical Research

Volumn 26, Issue 8-9, 2001, Pages 1001-1006

  Balla, Andrea ^a   Hashim, Audrey ^a   Burch, Sarah ^a   Javitt, Daniel C ^a   Lajtha, Abel ^a   Sershen, Henry ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Amphetamine; Dopamine; Phencyclidine; Prefrontal cortex; Schizophrenia; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOMIFENSINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ELECTROSTIMULATION; MALE; MICRODIALYSIS; MINIPUMP; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

AMPHETAMINES; ANIMALS; CORPUS STRIATUM; DOPAMINE; MALE; MICRODIALYSIS; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034760532     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012396820510     Document Type: Article

References (21)

1. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
2. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
3. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats
4. Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: Implications for schizophrenia
5. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
6. Recent advances in the phencyclidine model of schizophrenia
7. Inhibition of PCP-induced dopaminergic dysregulation by orally administered glycine in rodents: Model for schizophrenia treatment
8. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis
9. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex
10. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine
11. A. E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
12. Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum
13. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: An effect mediated by ventral tegmental area
14. Chronic phencyclidine increases NMDA receptor NRI subunit mRNA in rat forebrain
15. Extracellular dopamine and amphetamine after systemic amphetamine administration: Comparison to the behavioral response
16. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter
17. Dopamine and serotonin transporters in patients with schizophrenia: An imaging study with [(123)I]beta-CIT
18. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors
19. Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: In vitro voltammetric assessment
20. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release